Analyst firms · Raymond James · RVMD

Raymond James RVMD price target and rating history

Revolution Medicines Inc. (RVMD) · Health Care

Raymond James rates Revolution Medicines Inc. (RVMD) Strong Buy with a $72 price target, as of its latest action on Sep 12, 2025. It has published 3 rating actions on RVMD since November 2023, including 1 upgrade and 0 downgrades. Across 5 firms with a RVMD price target in the last 12 months, the median target is $179.

Current rating
Strong Buy
Price target
$72
Median target, all firms
$179
Actions on RVMD
3

Raymond James price target on RVMD

$72$51$30202420252026
Raymond James price target on RVMD, each point a stated target, November 2023 to September 2025.

Every Raymond James rating on RVMD

How other firms rate RVMD

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
William BlairOutperformOct 16, 2026
Goldman SachsBuy$267Sep 24, 2026
Morgan StanleyOverweight$255Sep 10, 2026
BernsteinMkt Perform$151May 22, 2026
Truist SecuritiesBuy$179May 18, 2026
JefferiesBuyMar 16, 2026
UBSBuy$145Feb 27, 2026

Questions about Raymond James and RVMD

What is Raymond James's price target for RVMD?
Raymond James's latest stated price target for Revolution Medicines Inc. (RVMD) is $72, from its action on Sep 12, 2025.
What is Raymond James's rating on RVMD?
Raymond James rates RVMD Strong Buy, a bullish rating, as of Sep 12, 2025.
When did Raymond James last change its view on RVMD?
On Sep 12, 2025, Raymond James resumes coverage at Strong Buy, price target $72.
How does Raymond James's RVMD target compare with other analysts?
Across 5 firms with a RVMD price target in the last 12 months, the median target is $179.

More RVMD rating histories

All Raymond James ratingsRVMD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.